6 unknown. 6 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Unknown 6 |
| Phase 2 | 1 | Unknown 1 |
Follow Medulloblastoma: new trials by email Literature Review of Medulloblastoma trials Research Report on Medulloblastoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors NKG2D-based CAR T-cells - Hepatocellular Carcinoma, Glioblastoma | Phase 1 | Unknown | Fudan University | 3 | 2021-03-01 | 2021-11-23 |
| A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors ZSP1602 - Basal Cell Carcinoma, Medulloblastoma | Phase 1 | Unknown | Guangdong Zhongsheng Pharmaceutical Co., Ltd. | 65 | 2019-01-25 | 2020-07-22 |
| Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors Carboplatin, Mannitol, Melphalan - Central Nervous System Embryonal Neoplasm, Embryonal Tumor With Multilayered Rosettes, C19MC-Altered | Phase 1 / Phase 2 | Unknown | OHSU Knight Cancer Institute | 17 | 2009-07-09 | 2021-10-26 |
| Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features Seneca Valley Virus (biological agent) - Carcinoid, Neuroendocrine | Phase 1 | Unknown | Neotropix | 60 | 2006-04-01 | 2010-02-25 |
| Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma erlotinib hydrochloride, mutation analysis, polymorphism analysis - Brain and Central Nervous System Tumors | Phase 1 | Unknown | Children's Cancer and Leukaemia Group | 48 | 2005-05-01 | 2013-09-20 |
| Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors verteporfin, conventional surgery - Brain and Central Nervous System Tumors, Metastatic Cancer | Phase 1 | Unknown | Medical College of Wisconsin | 24 | 1994-05-01 | 2013-09-20 |
Glioblastoma (4) · Astrocytoma (2) · Central Nervous System Neoplasms (2) · Choroid Plexus Neoplasms (2) · Familial ependymoma (2) · Neuroectodermal Tumors, Primitive (2) · Optic Nerve Glioma (2) · Brain Neoplasms (1) · Carcinoid Tumor (1) · Carcinoma, Basal Cell (1) · Carcinoma, Hepatocellular (1) · Colonic Neoplasms (1) · Craniopharyngioma (1) · Ependymoma (1)
Glioma (6) · Neoplasms (6) · Neoplasms by Histologic Type (6) · Neoplasms, Glandular and Epithelial (6) · Neoplasms, Nerve Tissue (6) · Neuroectodermal Tumors (6) · Neoplasms by Site (5) · Neoplasms, Germ Cell and Embryonal (5) · Neoplasms, Neuroepithelial (5) · Neuroectodermal Tumors, Primitive (4) · Astrocytoma (3) · Carcinoma (3) · Eye Diseases (3) · Adenocarcinoma (2) · Brain Diseases (2)
Amplified Fragment Length Polymorphism Analysis (1) · Biological Factors (1) · Carboplatin (1) · Erlotinib Hydrochloride (1) · Mannitol (1) · Melphalan (1) · Radiotherapy (1) · Verteporfin (1) · sodium thiosulfate (1)
Children's Cancer and Leukaemia Group (1) · Fudan University (1) · Guangdong Zhongsheng Pharmaceutical Co., Ltd. (1) · Medical College of Wisconsin (1) · Neotropix (1) · OHSU Knight Cancer Institute (1)
United States (3) · China (2) · Ireland (1) · United Kingdom (1)
Changchun Cai, doctor (1) · Darren Hargrave, MD (1) · Edward A Neuwelt (1) · Harry T. Whelan, MD (1) · Rudin Charles, MD, PhD (1)
R01NS044687 (1)